US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist

2.155
-0.022-0.99%

Close May 10 16:00 ET

2.150
-0.005-0.23%

Post 19:47 ET

18.22MMarket Cap-1456P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

(Q1)Jul 31, 2022

(FY)Apr 30, 2022

(Q4)Apr 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

67.31%-177.1K

-5.59%-1.98M

131.63%342.96K

7.86%-3.79M

75.80%-288.39K

-81.39%-541.7K

-35.63%-1.88M

12.64%-1.08M

-23.61%-4.12M

-26.75%-1.19M

Net income from continuing operations

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

-91.94%-1.88M

-50.67%-1.55M

-19.37%-4.24M

-48.20%-1.42M

Operating gains losses

---230K

---3.31M

--1.98M

----

Other non cash items

----

40,007.11%913.64K

399.40%174.02K

91.21%5.88K

6,692.30%165.87K

--0

-90.80%2.28K

-50.45%34.85K

-41.01%3.07K

Change In working capital

123.67%135.74K

-7,954.17%-554.61K

39.82%630.62K

-3,387.23%-297.17K

-175.60%-167.93K

-215.94%-573.37K

98.41%-6.89K

263.55%451.01K

106.21%9.04K

221.69%222.13K

-Change in prepaid assets

-66.46%25.43K

-2.57%-234.54K

-71.18%19.03K

35.80%-13.51K

-8.26%73.33K

11.97%75.8K

-392.17%-228.66K

126.74%66.02K

-130.21%-21.04K

354.37%79.93K

-Change in payables and accrued expense

116.99%110.31K

-244.32%-320.07K

58.86%611.59K

-1,033.17%-283.66K

-269.66%-241.25K

-252.08%-649.17K

143.50%221.78K

1,435.05%384.99K

114.12%30.4K

41.53%142.2K

-Change in other current assets

----

--0

----

---316

--0

Cash from discontinued investing activities

Operating cash flow

67.31%-177.1K

-5.59%-1.98M

131.63%342.96K

7.86%-3.79M

75.80%-288.39K

-81.39%-541.7K

-35.63%-1.88M

12.64%-1.08M

-23.61%-4.12M

-26.75%-1.19M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Investing cash flow

---5M

--0

Financing cash flow

Cash flow from continuing financing activities

-86.31%-7.04M

122.12%748.69K

400.44%6.28M

-115.53%-13.56M

-8,376.76%-4.31M

-3.78M

-103.87%-3.39M

-2.09M

1,783.00%87.31M

-200.00%-50.81K

Net issuance payments of debt

----

--0

----

18.63%-50.81K

----

Net common stock issuance

89.39%-400.71K

95.13%-164.95K

-1,165.39%-26.46M

-115.52%-13.56M

-113.60%-4.31M

---3.78M

-106.08%-3.39M

---2.09M

1,759.06%87.36M

--31.67M

Net preferred stock issuance

---6.64M

---1.35M

--35M

----

--0

----

Proceeds from stock option exercised by employees

--0

-92.05%70

--880

--0

--880

--0

---31.67M

Net other financing activities

----

---2.26M

----

Cash from discontinued financing activities

Financing cash flow

-86.31%-7.04M

122.12%748.69K

400.44%6.28M

-115.53%-13.56M

-8,376.76%-4.31M

---3.78M

-103.87%-3.39M

---2.09M

1,783.00%87.31M

-200.00%-50.81K

Net cash flow

Beginning cash position

-4.60%73.43M

-9.20%74.66M

-20.33%68.04M

3,778.14%85.4M

-16.16%72.64M

-11.47%76.96M

8,471.89%82.23M

3,778.14%85.4M

146.08%2.2M

2,702.99%86.64M

Current changes in cash

-182.79%-12.22M

76.53%-1.24M

308.61%6.62M

-120.86%-17.35M

-269.78%-4.6M

-1,346.47%-4.32M

-106.12%-5.26M

-155.74%-3.17M

6,270.53%83.19M

-39.70%-1.24M

Effect of exchange rate changes

141.90%1.07K

-120.97%-1.59K

-65.41%451

-256.67%-7.25K

-248.87%-5.28K

-1,116.19%-2.55K

-124.78%-720

180.74%1.3K

248.53%4.63K

459.87%3.54K

End cash Position

-15.73%61.21M

-4.60%73.43M

-9.20%74.66M

-20.33%68.04M

-16.16%72.64M

-11.47%76.96M

8,471.89%82.23M

3,778.14%85.4M

Free cash flow

67.31%-177.1K

-5.59%-1.98M

131.63%342.96K

7.86%-3.79M

75.80%-288.39K

-81.39%-541.7K

-35.63%-1.88M

12.64%-1.08M

-23.61%-4.12M

-26.75%-1.19M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022	(Q1)Jul 31, 2022	(FY)Apr 30, 2022	(Q4)Apr 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	67.31%-177.1K	-5.59%-1.98M	131.63%342.96K	7.86%-3.79M	75.80%-288.39K	-81.39%-541.7K	-35.63%-1.88M	12.64%-1.08M	-23.61%-4.12M	-26.75%-1.19M
Net income from continuing operations	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K	-91.94%-1.88M	-50.67%-1.55M	-19.37%-4.24M	-48.20%-1.42M
Operating gains losses	---230K	---3.31M	--1.98M	----	----	----	----	----	----	----
Other non cash items	----	----	40,007.11%913.64K	399.40%174.02K	91.21%5.88K	6,692.30%165.87K	--0	-90.80%2.28K	-50.45%34.85K	-41.01%3.07K
Change In working capital	123.67%135.74K	-7,954.17%-554.61K	39.82%630.62K	-3,387.23%-297.17K	-175.60%-167.93K	-215.94%-573.37K	98.41%-6.89K	263.55%451.01K	106.21%9.04K	221.69%222.13K
-Change in prepaid assets	-66.46%25.43K	-2.57%-234.54K	-71.18%19.03K	35.80%-13.51K	-8.26%73.33K	11.97%75.8K	-392.17%-228.66K	126.74%66.02K	-130.21%-21.04K	354.37%79.93K
-Change in payables and accrued expense	116.99%110.31K	-244.32%-320.07K	58.86%611.59K	-1,033.17%-283.66K	-269.66%-241.25K	-252.08%-649.17K	143.50%221.78K	1,435.05%384.99K	114.12%30.4K	41.53%142.2K
-Change in other current assets	----	----	----	--0	----	----	----	----	---316	--0
Cash from discontinued investing activities
Operating cash flow	67.31%-177.1K	-5.59%-1.98M	131.63%342.96K	7.86%-3.79M	75.80%-288.39K	-81.39%-541.7K	-35.63%-1.88M	12.64%-1.08M	-23.61%-4.12M	-26.75%-1.19M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow	---5M	--0	--0	--0	--0	--0	--0	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	-86.31%-7.04M	122.12%748.69K	400.44%6.28M	-115.53%-13.56M	-8,376.76%-4.31M	-3.78M	-103.87%-3.39M	-2.09M	1,783.00%87.31M	-200.00%-50.81K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	18.63%-50.81K	----
Net common stock issuance	89.39%-400.71K	95.13%-164.95K	-1,165.39%-26.46M	-115.52%-13.56M	-113.60%-4.31M	---3.78M	-106.08%-3.39M	---2.09M	1,759.06%87.36M	--31.67M
Net preferred stock issuance	---6.64M	---1.35M	--35M	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	--0	--0	-92.05%70	--880	--0	--0	--0	--880	--0	---31.67M
Net other financing activities	----	----	---2.26M	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-86.31%-7.04M	122.12%748.69K	400.44%6.28M	-115.53%-13.56M	-8,376.76%-4.31M	---3.78M	-103.87%-3.39M	---2.09M	1,783.00%87.31M	-200.00%-50.81K
Net cash flow
Beginning cash position	-4.60%73.43M	-9.20%74.66M	-20.33%68.04M	3,778.14%85.4M	-16.16%72.64M	-11.47%76.96M	8,471.89%82.23M	3,778.14%85.4M	146.08%2.2M	2,702.99%86.64M
Current changes in cash	-182.79%-12.22M	76.53%-1.24M	308.61%6.62M	-120.86%-17.35M	-269.78%-4.6M	-1,346.47%-4.32M	-106.12%-5.26M	-155.74%-3.17M	6,270.53%83.19M	-39.70%-1.24M
Effect of exchange rate changes	141.90%1.07K	-120.97%-1.59K	-65.41%451	-256.67%-7.25K	-248.87%-5.28K	-1,116.19%-2.55K	-124.78%-720	180.74%1.3K	248.53%4.63K	459.87%3.54K
End cash Position	-15.73%61.21M	-4.60%73.43M	-9.20%74.66M	-20.33%68.04M	-20.33%68.04M	-16.16%72.64M	-11.47%76.96M	8,471.89%82.23M	3,778.14%85.4M	3,778.14%85.4M
Free cash flow	67.31%-177.1K	-5.59%-1.98M	131.63%342.96K	7.86%-3.79M	75.80%-288.39K	-81.39%-541.7K	-35.63%-1.88M	12.64%-1.08M	-23.61%-4.12M	-26.75%-1.19M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall